Decision ruleHaematology

Revised International Staging System for multiple myeloma (R-ISS)

Combines the ISS with high-risk FISH cytogenetics and LDH to stage newly diagnosed myeloma.

Updated 31 October 2026

When to use it

Patients with newly diagnosed multiple myeloma with FISH on purified plasma cells and LDH available.

What it needs

  • Serum β2-microglobulinUnits: mg/L, nmol/L
  • Serum albuminUnits: g/dL, g/L
  • High-risk FISH cytogenetics: del(17p), t(4;14) or t(14;16)Yes or no
  • LDH above the upper limit of normalYes or no

The points for each answer and the automatic total are in the app.

How to interpret it

The result is read in its clinical context; the app shows it with its units and warnings.

In the app it also calculates: R-ISS stage.

Practical tip

High-risk cytogenetics = del(17p), t(4;14) or t(14;16) by FISH; other lesions (such as 1q gain) do not count in the R-ISS.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top